Icosapent ethyl reduces MI events in statin-treated patients | Latest news for Doctors, Nurses and Pharmacists | Pharmacy - MIMS
In the REDUCE-IT STEMI trial, icosapent ethyl (IPE) reduced MI events overall and across an array of MI subtypes in statin-treated patients at increas...
In the REDUCE-IT STEMI trial, icosapent ethyl (IPE) reduced MI events overall and across an array of MI subtypes in statin-treated patients at increased cardiovascular (CV) risk.
In the overall MI a… [+4168 chars]
Read More
Other Stories in Health
- Dosa saree, Idli shirt and a pani puri watch? AI turns desi food into fashion
- Where and why men die younger: global data breaks it down
- 8 Best Foldable Rowing Machines, According to Editors and Certified Trainers
- Strawberry Lemon Cream Crepes {Grain-Free Options Included}
- What predicts belief in the afterlife? A massive global study has answers
- Getting active in midlife may boost brain resilience to Alzheimer’s
- May 2025 Cooking Challenge
- May 2025 Cooking Challenge
- TDP-43 dysfunction in brain blood vessels may drive Alzheimer's and ALS progression
.png)
